Medications starting with

Italy
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

  • VYEPTI

    VYEPTI is used to prevent migraine in adults who suffer from it at least 4 days per month. It can reduce the number of migraine days and improve quality of life.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    eptinezumab -

    ATC code: N02CD05

    Manufacturer: H. LUNDBECK A/S

  • VYLOY

    This medicinal product is used to treat adult patients with gastric cancer or gastro-oesophageal junction cancer (the point where the oesophagus meets the stomach), when the tumour cannot be surgically removed or has spread to other parts of the body. It is administered to patients whose tumours are positive for the Claudin 18.2 protein and negative for the HER2 protein.

    Dosage form: powder for concentrate for infusion solution

    Active substance Dosage
    zolbetuximab -

    ATC code: L01FX31

    Manufacturer: ASTELLAS PHARMA EUROPE B.V.

  • VYNDACEL

    It is used for the treatment of transthyretin amyloidosis, a condition caused by the malfunction of a protein that can affect the nerves or the heart.

    Dosage form: capsules, soft gelatin

    Active substance Dosage
    tafamidis -

    ATC code: N07XX08

    Manufacturer: PFIZER EUROPE MA EEIG

  • VYTORIN

    It is used to decrease levels of total cholesterol, 'bad' cholesterol (LDL), and triglycerides in the blood, while simultaneously increasing 'good' cholesterol (HDL) levels. It is indicated for patients who cannot control cholesterol through diet alone or for those with heart disease, in order to reduce the risk of heart attack or stroke.

    Dosage form: tablets

    Active substance Dosage
    ezetimibe -
    simvastatin -

    ATC code: C10BA02

    Manufacturer: NEOPHARMED GENTILI S.P.A.

  • VYVGART

    It is used for the treatment of adults with generalized myasthenia gravis (gMG) and for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), both autoimmune diseases that cause muscle weakness.

    Dosage form: solution for infusion, concentrate

    Active substance Dosage
    efgartigimod alfa -

    ATC code: L04AA58

    Manufacturer: ARGENX BV

  • VYXEOS LIPOSOMAL

    It is used for the treatment of patients with a new diagnosis of acute myeloid leukemia, both when caused by previous treatments and when certain alterations are present in the bone marrow.

    Dosage form: powder for concentrate for infusion solution

    Active substance Dosage
    cytarabine -

    ATC code: L01XY01

    Manufacturer: JAZZ PHARMACEUTICALS IRELAND LIMITED